Filing Details
- Accession Number:
- 0001694665-22-000087
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-31 16:15:27
- Reporting Period:
- 2022-05-27
- Accepted Time:
- 2022-05-31 16:15:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1694665 | Evelo Biosciences Inc. | EVLO | Pharmaceutical Preparations (2834) | 465594527 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1738896 | Duncan Mchale | C/O Evelo Biosciences, Inc. 620 Memorial Drive Cambridge MA 02139 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-05-27 | 34,246 | $1.46 | 34,246 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
